“…Indeed, a proportion of EVs identified in the uterine lumen during early pregnancy [55] have been shown to be uniquely contributed by the foetus [34,56,57,150,154], and levels of placental EVs increase in human maternal circulation across gestation [155]. Embryo-derived EVs can interact with various cell types associated with the uterus (e.g., endometrium, immune [156] cells) to modulate processes implicated in receptivity [84,157,158] in addition to remodelling the extracellular matrix [158,159]-a critical network in supporting the development and implantation competence of human embryos [160]. Because of the very small quantity of EVs released by an embryo, cells of trophectodermal [84,[157][158][159] or embryonic [33,34,53,129] origin remain the most widely used approaches to understand their composition and function (Table 2).…”